AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15454352 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (50 mg/day)
Number of subjects: 55
Study 15454352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 11474160 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril
Number of subjects: 57
Study 11474160 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 57
Study 9709140 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium bromide 0.25 ml (0.5 mg)
Number of subjects: 60
Study 9709140 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline 0.25 ml
Number of subjects: 60
Study 8574271 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxandrolone (ASOX)
Number of subjects: 30
Study 8574271 — intervention group
Group type: COMPARATOR
Intervention: Testosterone enanthate (TE)
Number of subjects: 30
Study 8574271 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nandrolone decanoate (ASND)
Number of subjects: 30
Study 8574271 — intervention group
Group type: COMPARATOR
Intervention: Weight loss alone (PL)
Number of subjects: 30
Study 2159509 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sodium diet (200 mmol/day)
Number of subjects: 18
Study 2159509 — intervention group
Group type: COMPARATOR
Intervention: Low-sodium diet (20 mmol/day)
Number of subjects: 18
Study 380595 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloramphenicol plus oxyphenbutazone
Number of subjects: 94
Study 380595 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloramphenicol alone
Number of subjects: 94
Study 380595 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin plus oxyphenbutazone
Number of subjects: 94
Study 380595 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 94
Study 31272550 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab 1,000 mg intravenous on days 0 and 12 post-transplant
Number of subjects: 163
Study 31272550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 31272550 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 163
Study 28948482 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 90-mg dose of hydrocodone ER under fed conditions
Number of subjects: 83
Study 28948482 — intervention group
Group type: COMPARATOR
Intervention: Single 90-mg dose of hydrocodone ER under fasted conditions
Number of subjects: 83
Study 28948482 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of hydrocodone ER (45 mg twice daily on days 2-3, 60 mg twice daily on days 4-5, 90 mg twice daily on days 6-10, and 90 mg once in the morning on day 11) under fed conditions
Number of subjects: 83
Study 28948482 — intervention group
Group type: COMPARATOR
Intervention: Multiple doses of hydrocodone ER under fasted conditions
Number of subjects: 83
Study 26149601 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzydamine hydrochloride (BH) spray
Number of subjects: 92
Study 24579355 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES) combined with general anesthesia
Number of subjects: 60
Study 24579355 — intervention group
Group type: COMPARATOR
Intervention: Control group received simple general anesthesia
Number of subjects: 60
Study 21661100 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspart insulin protocol every 2 hours when BG > 200 mg/dL, and if admitted, began daily detemir in the ED
Number of subjects: 176
Study 21661100 — intervention group
Group type: COMPARATOR
Intervention: Usual care (treated per hospital physicians)
Number of subjects: 176
Study 21661100 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspart insulin protocol
Number of subjects: 176
Study 21661100 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 176
Study 17983882 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative group (reduction mammaplasty)
Number of subjects: 82
Study 17983882 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative group
Number of subjects: 82
Study 16926601 — intervention group
Group type: EXPERIMENTAL
Intervention: tacrolimus/mycophenolate mofetil (FK/MMF)
Number of subjects: 91
Study 16926601 — intervention group
Group type: COMPARATOR
Intervention: cyclosporine/azathioprine (CSA/Aza)
Number of subjects: 91
Study 14607455 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS (20 IU/kg intravenously)
Number of subjects: 9
Study 14607455 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (24 mg/min)
Number of subjects: 9
Study 14607455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 11087767 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (mean dose, 1.8 mg/d)
Number of subjects: 149
Study 11087767 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (mean dose, 200 mg/d)
Number of subjects: 149
Study 11087767 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior Management Techniques (BMT)
Number of subjects: 149
Study 11087767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 1836616 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 30
Study 1836616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 7084867 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation therapy combined with vitamin A palmitate (1.5 mill. I.U./day; total dose: 30 mill. I.U.), applied orally
Number of subjects: 0
Study 7084867 — intervention group
Group type: COMPARATOR
Intervention: Irradiation alone
Number of subjects: 0
Study 7084867 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation therapy combined with vitamin A palmitate
Number of subjects: 0
Study 30204741 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical decolonization with nasal mupirocin and chlorhexidine body wash
Number of subjects: 1350
Study 30204741 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 1350
Study 30188971 — intervention group
Group type: EXPERIMENTAL
Intervention: GLIDE method for evaluating pleiotropy among genetic variants (SNPs)
Number of subjects: 0
Study 30188971 — intervention group
Group type: EXPERIMENTAL
Intervention: GLIDE method
Number of subjects: 0
Study 30188971 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of potentially pleiotropic SNPs
Number of subjects: 0
Study 26967008 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluid intake after tonsillectomy (mean 18.2 mL/kg, SD 10.8 mL/kg)
Number of subjects: 473
Study 25203377 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of intersphincteric fistula track
Number of subjects: 70
Study 25203377 — intervention group
Group type: COMPARATOR
Intervention: Mucosal advancement flap
Number of subjects: 70
Study 22794154 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of clozapine (100 mg)
Number of subjects: 26
Study 22794154 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of clozapine (100 mg)
Number of subjects: 26
Study 22794154 — intervention group
Group type: EXPERIMENTAL
Intervention: Both test and reference formulations of clozapine
Number of subjects: 26
Study 20728210 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab plus chemotherapy
Number of subjects: 594
Study 20728210 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 594
Study 17664517 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus telephone monitoring and care management
Number of subjects: 104
Study 17664517 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus care management plus peer-led chronic-disease self-management group
Number of subjects: 104
Study 17664517 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus care management plus professionally led depression psychotherapy group
Number of subjects: 104
Study 17664517 — intervention group
Group type: COMPARATOR
Intervention: Usual behavioral health care
Number of subjects: 104
Study 16362506 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary volume
Number of subjects: 39
Study 16362506 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary volume/salivary pH
Number of subjects: 39
Study 16362506 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary volume and salivary pH x volume
Number of subjects: 39
Study 11886002 — intervention group
Group type: EXPERIMENTAL
Intervention: Treosulfan 7 g/m2 infused over 30 min, repeated every 4 weeks
Number of subjects: 78
Study 11886002 — intervention group
Group type: COMPARATOR
Intervention: Leuprorelin 3.75 mg injected subcutaneously or intramuscularly, repeated every 4 weeks
Number of subjects: 78
Study 10082251 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepilepsirine (AES) 10 mg/kg per day
Number of subjects: 58
Study 10082251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 7676784 — intervention group
Group type: EXPERIMENTAL
Intervention: enflurane 0.3% - nitrous oxide
Number of subjects: 40
Study 7676784 — intervention group
Group type: EXPERIMENTAL
Intervention: enflurane 0.6% - nitrous oxide
Number of subjects: 40
Study 7676784 — intervention group
Group type: EXPERIMENTAL
Intervention: enflurane 0.9% - nitrous oxide
Number of subjects: 40
Study 7676784 — intervention group
Group type: COMPARATOR
Intervention: control (fentanyl-nitrous oxide anaesthesia)
Number of subjects: 40
Study 2308759 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzydamine 3% cream
Number of subjects: 0
Study 2308759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6349650 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium (300 mg per day for a maximum of 3 weeks)
Number of subjects: 161
Study 6349650 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (150 mg per day)
Number of subjects: 161
Study 6349650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study 6349650 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium
Number of subjects: 161
Study 6349650 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 161
Study 31232675 — intervention group
Group type: EXPERIMENTAL
Intervention: Body acceptance intervention
Number of subjects: 19
Study 30872176 — intervention group
Group type: EXPERIMENTAL
Intervention: Technique protecting blood supply to the superior parathyroid
Number of subjects: 113
Study 30872176 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 113
Study 29458842 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish Oil (FO)
Number of subjects: 0
Study 29458842 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry (BB)
Number of subjects: 0
Study 29458842 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined FO + BB
Number of subjects: 0
Study 29458842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26731485 — intervention group
Group type: EXPERIMENTAL
Intervention: Food allergen challenge
Number of subjects: 362
Study 26731485 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 362
Study 24577287 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4CBT
Number of subjects: 101
Study 24577287 — intervention group
Group type: COMPARATOR
Intervention: Standard methadone maintenance
Number of subjects: 101
Study 24343688 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure of 10 cmH2O (Group C)
Number of subjects: 136
Study 24343688 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure of 8 cmH2O (Group B)
Number of subjects: 136
Study 24343688 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure of 5 cmH2O (Group A)
Number of subjects: 136
Study 20129212 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril (6 months)
Number of subjects: 257
Study 20129212 — intervention group
Group type: COMPARATOR
Intervention: Placebo (6 months)
Number of subjects: 257
Study 18196446 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured early consultation with the occupational physician (OP)
Number of subjects: 299
Study 18196446 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 299
Study 18196446 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured early consultation with the OP
Number of subjects: 299
Study 16225558 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 93
Study 16225558 — intervention group
Group type: COMPARATOR
Intervention: Non-psychoeducation (Control)
Number of subjects: 93
Study 12797942 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial filter (used in phase 1)
Number of subjects: 65
Study 12797942 — intervention group
Group type: COMPARATOR
Intervention: No antimicrobial filter (used in phase 2)
Number of subjects: 65
Study 12797942 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations of SEPAR for disinfecting lung function equipment
Number of subjects: 65
Study 12797942 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial filter
Number of subjects: 65
Study 10567956 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab (20 mg injections, one prior to surgery and one on Day 4 posttransplant)
Number of subjects: 39
Study 10567956 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation method for prediction
Number of subjects: 39
Study 10567956 — intervention group
Group type: EXPERIMENTAL
Intervention: First-order approximation methods (inverse regression and inversion of confidence intervals)
Number of subjects: 39
Study 8671319 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 microgram dose of desogestrel
Number of subjects: 44
Study 8671319 — intervention group
Group type: COMPARATOR
Intervention: 30 microgram dose of desogestrel
Number of subjects: 44
Study 8671319 — intervention group
Group type: COMPARATOR
Intervention: 50 microgram dose of desogestrel
Number of subjects: 44
Study 1751794 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin (100 to 150 U/kg)
Number of subjects: 151
Study 1751794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 1751794 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin (25 U/kg)
Number of subjects: 151
Study 1751794 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin (100 U/kg)
Number of subjects: 151
Study 1751794 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin (200 U/kg)
Number of subjects: 151
Study 1751794 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin (all doses combined)
Number of subjects: 151
Study 1751794 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 151
Study 6753888 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral disopyramide phosphate (loading dose of 150, 200, or 300 mg followed by maintenance doses of 100, 150, or 200 mg every 6 hours based on weight)
Number of subjects: 101
Study 6753888 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral disopyramide phosphate
Number of subjects: 101
Study 31207334 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 27844152 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-directed therapy (n = 26)
Number of subjects: 79
Study 27844152 — intervention group
Group type: EXPERIMENTAL
Intervention: SwallowIT-assisted therapy (n = 26)
Number of subjects: 79
Study 27844152 — intervention group
Group type: COMPARATOR
Intervention: Patient-directed therapy (n = 27)
Number of subjects: 79
Study 27844152 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (n = 79)
Number of subjects: 79
Study 27844152 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline factors
Number of subjects: 79
Study 24593317 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-free essential oil mouthwash (AF-EOMW) used twice a day
Number of subjects: 25
Study 24593317 — intervention group
Group type: COMPARATOR
Intervention: Tap water (control)
Number of subjects: 25
Study 25588917 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored education, doctor's reminder, and cost reduction
Number of subjects: 448
Study 25588917 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost reduction
Number of subjects: 448
Study 25588917 — intervention group
Group type: COMPARATOR
Intervention: Other intervention arms (without cost reduction)
Number of subjects: 448
Study 21380536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser treatment (630-670 nm, 1.875 J/cm²) plus scaling and root planing (SRP) for five consecutive days
Number of subjects: 60
Study 21380536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser treatment (630-670 nm, 1.875 J/cm²) plus scaling and root planing (SRP) for ten consecutive days
Number of subjects: 60
Study 21380536 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) on a single quadrant/day for four consecutive days
Number of subjects: 60
Study 21380536 — intervention group
Group type: COMPARATOR
Intervention: Control group (no periodontal disease)
Number of subjects: 60
Study 19056656 — intervention group
Group type: COMPARATOR
Intervention: Control spread (n = 87)
Number of subjects: 217
Study 19056656 — intervention group
Group type: EXPERIMENTAL
Intervention: Spread with plant sterol esters (1.1 g/d or 2.2 g/d plant sterols; n = 120)
Number of subjects: 217
Study 17888974 — intervention group
Group type: EXPERIMENTAL
Intervention: CorCap Cardiac Support Device (CSD) with mitral surgery
Number of subjects: 300
Study 17888974 — intervention group
Group type: EXPERIMENTAL
Intervention: CorCap Cardiac Support Device (CSD)
Number of subjects: 300
Study 17888974 — intervention group
Group type: COMPARATOR
Intervention: Control group (mitral surgery alone or medical therapy)
Number of subjects: 300
Study 15002024 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% in the evening (2000 hours)
Number of subjects: 103
Study 15002024 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5% twice daily (0800 and 2000 hours)
Number of subjects: 103
Study 11696289 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication
Number of subjects: 0
Study 9702915 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (0.35% of total fatty acids)
Number of subjects: 108
Study 9702915 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (0.36%) and AA (0.72%)
Number of subjects: 108
Study 9702915 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented infants
Number of subjects: 108
Study 9702915 — intervention group
Group type: COMPARATOR
Intervention: All diet groups
Number of subjects: 108
Study 8011964 — intervention group
Group type: EXPERIMENTAL
Intervention: Caplet formulation (product A)
Number of subjects: 14
Study 8011964 — intervention group
Group type: COMPARATOR
Intervention: Tablet formulation (product B)
Number of subjects: 14
Study 2637335 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand instrumentation with K-Flex files
Number of subjects: 105
Study 2637335 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic instrumentation with the Endostar 5
Number of subjects: 105
Study 2637335 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic instrumentation with the Sonic Air MM 3000
Number of subjects: 105
Study 2637335 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic instrumentation with the Cavi-Endo unit
Number of subjects: 105
Study 2637335 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 105
Study 770150 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine plus Lithium Carbonate
Number of subjects: 30
Study 770150 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine plus placebo
Number of subjects: 30
Study 31205190 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 148
Study 31205190 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 148
Study 31205190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 28800765 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil administered preoperatively (n=16)
Number of subjects: 45
Study 28800765 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil administered post-MTS (n=14)
Number of subjects: 45
Study 28800765 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=15)
Number of subjects: 45
Study 24612471 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on Surgical Training (HoST) technology group
Number of subjects: 52
Study 24612471 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 22397878 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-CHO/high-monounsaturated-fat diet (M)
Number of subjects: 104
Study 22397878 — intervention group
Group type: EXPERIMENTAL
Intervention: High-CHO/low-GI diet (L)
Number of subjects: 104
Study 22397878 — intervention group
Group type: COMPARATOR
Intervention: High-CHO/high-GI diet (H)
Number of subjects: 104
Study 21335122 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediastinal lymph node sampling
Number of subjects: 1023
Study 21335122 — intervention group
Group type: COMPARATOR
Intervention: Mediastinal lymph node dissection
Number of subjects: 1023
Study 18093792 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 100
Study 18093792 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients with a history of myocardial infarction or stroke
Number of subjects: 100
Study 18093792 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 100
Study 16002439 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of vestibular nerves to evoke virtual head rotation
Number of subjects: 0
Study 16002439 — intervention group
Group type: EXPERIMENTAL
Intervention: Model based on vector operations and anatomy of semicircular canals
Number of subjects: 0
Study 12538184 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 63
Study 12538184 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine dorsal penile nerve block
Number of subjects: 63
Study 12538184 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 63
Study 12538184 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride solution dorsal penile block
Number of subjects: 63
Study 10775890 — intervention group
Group type: EXPERIMENTAL
Intervention: TRY- (low tryptophan diet with amino acid mixture without tryptophan)
Number of subjects: 30